FAC Explorer

Audit 316965

FY End
2023-12-31
Total Expended
$2.58M
Findings
0
Programs
2
Organization: Naprogenix, Inc. (KY)
Year: 2023 Accepted: 2024-08-09
Auditor: Dean Dorton Allen Ford PLLC

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.273 Alcohol Research Programs $2.28M Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $300,502 Yes 0

Contacts

Name Title Type
N1NBJ43SQGX7 Cindy Burklow Auditee
8592571127 Megan Crane Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported in conformity with accounting principles generally accepted in the United States of America (GAAP) basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.